Weber T - Search Results

1

Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels.

Kohlbrenner E, Henckaerts E, Rapti K, Gordon RE, Linden RM, Hajjar RJ, Weber T. Kohlbrenner E, et al. Among authors: weber t. Hum Gene Ther Methods. 2012 Jun;23(3):198-203. doi: 10.1089/hgtb.2012.049. Epub 2012 Jul 20. Hum Gene Ther Methods. 2012. PMID: 22816378 Free PMC article.

2

Altering AAV tropism with mosaic viral capsids.

Gigout L, Rebollo P, Clement N, Warrington KH Jr, Muzyczka N, Linden RM, Weber T. Gigout L, et al. Among authors: weber t. Mol Ther. 2005 Jun;11(6):856-65. doi: 10.1016/j.ymthe.2005.03.005. Mol Ther. 2005. PMID: 15922956 Free article.

3

Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction.

Hirosue S, Senn K, Clément N, Nonnenmacher M, Gigout L, Linden RM, Weber T. Hirosue S, et al. Among authors: weber t. Virology. 2007 Oct 10;367(1):10-8. doi: 10.1016/j.virol.2007.05.009. Epub 2007 Jun 22. Virology. 2007. PMID: 17588632 Free PMC article.

4

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors.

Zeltner N, Kohlbrenner E, Clément N, Weber T, Linden RM. Zeltner N, et al. Among authors: weber t. Gene Ther. 2010 Jul;17(7):872-9. doi: 10.1038/gt.2010.27. Epub 2010 Mar 25. Gene Ther. 2010. PMID: 20336156 Free PMC article.

5

Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.

Rapti K, Louis-Jeune V, Kohlbrenner E, Ishikawa K, Ladage D, Zolotukhin S, Hajjar RJ, Weber T. Rapti K, et al. Among authors: weber t. Mol Ther. 2012 Jan;20(1):73-83. doi: 10.1038/mt.2011.177. Epub 2011 Sep 13. Mol Ther. 2012. PMID: 21915102 Free PMC article.

6

Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts.

Karakikes I, Hadri L, Rapti K, Ladage D, Ishikawa K, Tilemann L, Yi GH, Morel C, Gwathmey JK, Zsebo K, Weber T, Kawase Y, Hajjar RJ. Karakikes I, et al. Among authors: weber t. Mol Ther. 2012 Mar;20(3):565-71. doi: 10.1038/mt.2011.268. Epub 2012 Jan 3. Mol Ther. 2012. PMID: 22215018 Free PMC article.

7

Intracellular transport of recombinant adeno-associated virus vectors.

Nonnenmacher M, Weber T. Nonnenmacher M, et al. Among authors: weber t. Gene Ther. 2012 Jun;19(6):649-58. doi: 10.1038/gt.2012.6. Epub 2012 Feb 23. Gene Ther. 2012. PMID: 22357511 Free PMC article. Review.

8

Gene therapy for heart failure.

Tilemann L, Ishikawa K, Weber T, Hajjar RJ. Tilemann L, et al. Among authors: weber t. Circ Res. 2012 Mar 2;110(5):777-93. doi: 10.1161/CIRCRESAHA.111.252981. Circ Res. 2012. PMID: 22383712 Free PMC article. Review.

9

Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.

Louis Jeune V, Joergensen JA, Hajjar RJ, Weber T. Louis Jeune V, et al. Among authors: weber t. Hum Gene Ther Methods. 2013 Apr;24(2):59-67. doi: 10.1089/hgtb.2012.243. Epub 2013 Apr 3. Hum Gene Ther Methods. 2013. PMID: 23442094 Free PMC article. Review.

10

Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure.

Chaanine AH, Nonnenmacher M, Kohlbrenner E, Jin D, Kovacic JC, Akar FG, Hajjar RJ, Weber T. Chaanine AH, et al. Among authors: weber t. Gene Ther. 2014 Apr;21(4):379-386. doi: 10.1038/gt.2014.7. Epub 2014 Feb 27. Gene Ther. 2014. PMID: 24572786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,566 results

Search Page

Filters